Methods and compositions involving (S)-bucindolol
AssigneeARCA Biopharma, Inc.
InventorsMichael R. Bristow, Jonathan D. Port
Life of this patent
Estimating the term…
Abstract
Disclosed is bucindolol substantially free of its R-stereoisomer. Also disclosed are pharmaceutical compositions that include bucindolol substantially free of its R-stereoisomer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Also disclosed are methods of treating a patient that involve administering to the patient a therapeutically effective amount of a composition of the present invention.
Claims8
A medical device comprising a coating, a matrix, or a chamber, wherein said coating, matrix, or chamber comprises bucindolol substantially free of the R-stereoisomer of said bucindolol, wherein the ratio of S-bucindolol to R-bucindolol in the coating, matrix, or chamber is at least about 99:1 by weight.
Dependencies are inferred from the claim text.